PT  - JOURNAL ARTICLE
AU  - Kelsey Peters
AU  - Drew Pratt
AU  - Carl Koschmann
AU  - Denise Leung
TI  - Prolonged survival in a patient with a cervical spine H3K27M-mutant diffuse midline glioma
AID  - 10.1136/bcr-2019-231424
DP  - 2019 Oct 01
TA  - BMJ Case Reports
PG  - e231424
VI  - 12
IP  - 10
4099  - http://casereports.bmj.com/content/12/10/e231424.short
4100  - http://casereports.bmj.com/content/12/10/e231424.full
SO  - BMJ Case Reports2019 Oct 01; 12
AB  - We report a case of prolonged survival in a patient with known cervical intramedullary H3K27M-mutant diffuse midline glioma. A 39-year-old man presented for evaluation with several months of progressive upper extremity pain and weakness. MRI of the cervical spine revealed an intramedullary ring-enhancing lesion centred at C3-C4. Following subtotal surgical resection, a diagnosis of glioblastoma (GBM) was confirmed. Subsequent testing at a later date revealed an H3K27M mutation. He was initially treated with radiation and concomitant and adjuvant temozolomide. He had multiply recurrent disease and was treated with various regimens, including the histone deacetylase inhibitor valproic acid. The patient passed away 31 months (~2.5 years) after diagnosis. Our case is one of few reported adult spinal cord GBMs possessing the H3K27M mutation, and one with the longest reported overall survival in the literature to date.